Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Light therapy mask may soothe dry eyes after cataract surgery

NCT ID NCT07067294

Symptom relief Sponsor: Grigore T. Popa University of Medicine and Pharmacy Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a low-level light therapy mask on 98 adults having cataract surgery. The mask was used one week before and one week after surgery to see if it could prevent or reduce dry eye symptoms. Researchers measured dry eye symptoms, tear stability, and eye surface health over six months. The goal is to find a safe, non-drug way to improve comfort and recovery after cataract surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low-level light therapy (LLLT) via a light-emitting mask
What this could lead to
If it works, this could offer a simple, non-invasive way to reduce dry eye discomfort after cataract surgery.
What could go wrong
This is a small, early-stage study with 98 participants. The treatment may not work for everyone, and long-term benefits are unclear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

98 people

The number who actually took part.

Started

Jan 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Consecutive adult patients (aged ≥18 years). * Scheduled for routine phacoemulsification cataract surgery. * Provided written informed consent and agreed to attend all follow-up visits. Exclusion Criteria: * Prior diagnosis of ocular surface disease (OSD) or dry eye disease (DED). * History of ocular surgery in either eye. * Presence of ocular comorbidities (e.g., glaucoma, uveitis, corneal dystrophies). * Current or regular use of topical ocular treatments such as lubricants, corticosteroids, or cyclosporine. * Ongoing or recent instrumental therapies or oral supplements for OSD or DED. * Use of systemic medications known to be associated with DED (e.g., diuretics, antidepressants, antihistamines, hormone replacement therapy). * History of autoimmune diseases (e.g., Sjögren's syndrome). * Regular contact lens wear. * Any intraoperative or postoperative complications that could interfere with ocular surface evaluation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry eye are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dry eye syndrome Meibomian Gland Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry eye Meibomian gland dysfunction (disorder) Ocular surface disease

Contacts and locations

Locations

  • University of Medicine and Pharmacy "Grigore T. Popa" Iași

    Iași, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.